Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
Aemetis India unit Universal Biofuels wins $17 million biodiesel allocation from state OMCs

Aemetis India unit Universal Biofuels wins $17 million biodiesel allocation from state OMCs

ReutersReuters2026/08/04 11:53
  • Aemetis India unit Universal Biofuels won allocations to supply 18 million liters of biodiesel to India’s three state-owned OMCs.
  • Deliveries span a three-month period; expected to generate about USD 17 million in revenue.
  • Kakinada plant capacity expanded to about 80 million gallons per year, supported by a proprietary enzymatic process to lower carbon intensity.
  • Universal is preparing for a potential India stock exchange IPO to sell a minority stake, subject to market conditions.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aemetis Inc. published the original content used to generate this news brief on August 04, 2026, and is solely responsible for the information contained therein.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Competition in US oral weight-loss drugs intensifies! Eli Lilly (LLY.US) Foundayo captures 30% of new patients, narrowing Novo Nordisk's (NVO.US) first-mover advantage

Eli Lilly stated on Monday that its oral weight-loss drug, Foundayo, has captured over 30% of the market share among new patients in the US oral obesity treatment market, narrowing the early lead achieved by Danish competitor Novo Nordisk with its Wegovy oral tablets.

智通财经2026/09/15 03:21
Competition in US oral weight-loss drugs intensifies! Eli Lilly (LLY.US) Foundayo captures 30% of new patients, narrowing Novo Nordisk's (NVO.US) first-mover advantage